Position in QGEN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$62,392,886
+$9,530,076 QoQ
Shares Held
1,595,726
+20.9% QoQ
Ownership
0.773%
of shares outstanding
% of Portfolio
11.49%
of 13F equity value
Holder Rank
#26
of 336 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in QGEN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026NUANCE INVESTMENTS, LLC holds $95,158,857 across 6 Diagnostics & Research names. QGEN ranks #1 (65.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | QGEN |
Qiagen N.V.
This page
|
1,595,726 | $62,392,886 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
35,664 | $17,880,503 | |
| 3 | DGX |
Quest Diagnostics Inc
|
27,470 | $5,822,266 | |
| 4 | WAT |
Waters Corp /De/
|
10,762 | $4,036,180 | |
| 5 | DHR |
Danaher Corp /De/
|
17,162 | $3,269,017 | |
| 6 | A |
Agilent Technologies, Inc.
|
13,235 | $1,758,005 |
All Filings in QGEN
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $62,392,886 | 1,595,726 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $52,862,810 | 1,320,250 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $36,137,352 | 803,588 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $24,074,522 | 538,821 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $65,257,742 | 1,357,839 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $111,550,712 | 2,778,349 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $184,577,384 | 4,145,012 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $204,743,913 | 4,492,954 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $216,605,688 | 5,271,494 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $193,175,092 | 4,493,489 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $48,998,091 | 1,093,234 | Shares | Sole | 2024-02-07 | |
| No filing history on record for this holder in this stock. | ||||||